Monash IVF Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Monash IVF GroupDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -5.9% zurückgegangen, während in der Branche Healthcare die Gewinne mit einer durchschnittlichen jährlichen Rate von 3.3% zurückgehen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 11% pro Jahr.

Wichtige Informationen

-5.9%

Wachstumsrate der Gewinne

-16.6%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	2.4%
Wachstumsrate der Einnahmen	11.0%
Eigenkapitalrendite	-2.4%
Netto-Marge	-2.6%
Letzte Ertragsaktualisierung	30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Nov 04

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

May 14

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Jun 06

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

May 25

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

May 13

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Mar 14

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Mar 04

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Feb 26

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

Feb 15

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

Feb 03

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Jan 22

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Jan 10

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

Dec 28

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Dec 17

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Dec 06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

Nov 24

Aufschlüsselung der Einnahmen und Ausgaben

Wie Monash IVF Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

ASX:MVF Einnahmen, Ausgaben und Erträge (AUD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Jun 24	255	-7	21
31 Mar 24	246	9	20
31 Dec 23	236	24	20
30 Sep 23	225	23	19
30 Jun 23	214	22	18
31 Mar 23	204	19	18
31 Dec 22	195	17	18
30 Sep 22	193	18	18
30 Jun 22	192	18	18
31 Mar 22	193	21	18
31 Dec 21	194	23	17
30 Sep 21	189	24	16
30 Jun 21	184	25	14
31 Mar 21	171	22	13
31 Dec 20	159	18	13
30 Sep 20	152	15	12
30 Jun 20	145	12	12
31 Mar 20	149	15	12
31 Dec 19	152	18	12
30 Sep 19	152	19	12
30 Jun 19	152	20	11
31 Mar 19	151	19	14
31 Dec 18	151	19	17
30 Sep 18	151	20	17
30 Jun 18	151	21	17
31 Mar 18	152	24	17
31 Dec 17	153	26	16
30 Sep 17	154	28	16
30 Jun 17	155	30	16
31 Mar 17	156	30	16
31 Dec 16	156	30	15
30 Sep 16	156	29	16
30 Jun 16	157	29	16
31 Mar 16	150	27	13
31 Dec 15	144	24	9
30 Sep 15	134	23	9
30 Jun 15	125	21	9
31 Mar 15	121	15	8
31 Dec 14	117	8	8
30 Sep 14	115	5	8
30 Jun 14	114	3	9
31 Mar 14	110	2	4
31 Dec 13	106	0	0

Qualität der Erträge: MVF ist derzeit unrentabel.

Wachsende Gewinnspanne: MVF ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: MVF ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 5.9% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von MVF verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: MVF ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Healthcare (-25.4%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: MVF hat eine negative Eigenkapitalrendite (-2.41%), da es derzeit unrentabel ist.

Monash IVF Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2024 earnings: EPS misses analyst expectations

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group's (ASX:MVF) Dividend Will Be A$0.025

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Price target increased by 7.3% to AU$1.42

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group (ASX:MVF) Will Pay A Dividend Of A$0.022

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Here's What's Concerning About Monash IVF Group's (ASX:MVF) Returns On Capital

Insufficient new directors

Shareholders Will Probably Not Have Any Issues With Monash IVF Group Limited's (ASX:MVF) CEO Compensation

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Consensus forecasts updated

Upcoming dividend of AU$0.022 per share

Monash IVF Group's (ASX:MVF) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2022 earnings: EPS misses analyst expectations

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Consensus EPS estimates fall by 16%

Be Wary Of Monash IVF Group (ASX:MVF) And Its Returns On Capital

Consensus EPS estimates fall by 10%

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Price target increased to AU$1.08

Should You Think About Buying Monash IVF Group Limited (ASX:MVF) Now?

Monash IVF Group (ASX:MVF) May Have Issues Allocating Its Capital

Is Monash IVF Group Limited (ASX:MVF) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Director recently bought AU$192k worth of stock

Is Monash IVF Group Limited (ASX:MVF) A Smart Choice For Dividend Investors?

Just Four Days Till Monash IVF Group Limited (ASX:MVF) Will Be Trading Ex-Dividend

Monash IVF Group Limited (ASX:MVF) Just Released Its Half-Year Results And Analysts Are Updating Their Estimates

Revenue and earnings beat expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

Is Now An Opportune Moment To Examine Monash IVF Group Limited (ASX:MVF)?

A Look At The Fair Value Of Monash IVF Group Limited (ASX:MVF)

We're Not So Sure You Should Rely on Monash IVF Group's (ASX:MVF) Statutory Earnings

Is Monash IVF Group Limited (ASX:MVF) Popular Amongst Institutions?

Is Monash IVF Group (ASX:MVF) Using Too Much Debt?

What Do The Returns On Capital At Monash IVF Group (ASX:MVF) Tell Us?

Monash IVF Group's (ASX:MVF) Shareholders Are Down 56% On Their Shares

Price target raised to AU$0.88

Analysts increase EPS estimates to AU$0.06

Monash IVF Group Limited's (ASX:MVF) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

New 90-day high: AU$0.71

Analysts increase EPS estimates to AU$0.053

Price target raised to AU$0.80